Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss SNDA Q1 2026 Earnings Miss on EPS as Operating Challenges Persist CLYM Q1 2026 Earnings NarrowerThanExpected Loss Supports Positive Investor Sentiment Kestrel Group Ltd Q3 2024 Earnings Loss Per Share of 016 Triggers Stock Decline SEPN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline APGE Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Surprise